-
Blenrep (Belantamab Mafodotin) – Multiple Myeloma
- Generic Name/Brand Name: Belantamab mafodotin/Blenrep
- Indications: Relapsed or refractory multiple myeloma (RRMM)
- Dosage Form: Lyophilized powder for IV infusion
- Specification: 100 mg/vial
-
Exdensur (Depemokimab) – Eosinophilic Asthma
- Generic Name/Brand Name: Depemokimab/Exdensur
- Indications: Severe Eosinophilic Asthma (≥12 years)
- Dosage Form: Injection
- Specification: 100 mg/1 mL × 1 prefilled syringe
-
Foundayo(Orforglipron) – Obesity/Overweight
- Generic Name/Brand Name: Orforglipron/Foundayo
- Indications: Obesity or overweight with comorbidities
- Dosage Form: Oral
- Specification: 0.8 mg / 2.5 mg / 5.5 mg / 9 mg / 14.5 mg / 17.2 mg per tablet × 30 tablets per box
-
Hyrnuo (Sevabertinib)
- Generic Name/Brand Name: Sevabertinib/Hyrnuo
- Indications: HER2-mutant non-small cell lung cancer (NSCLC)
- Dosage Form: Film-coated tablets
- Specification: 10 mg × 120 tablets per bottle
-
Lukeda (Rocbrutinib) – MCL
- Generic Name/Brand Name: Rocbrutinib/Lukeda
- Indications: Relapsed or refractory mantle cell lymphoma (R/R MCL)
- Dosage Form: Film-coated tablets
- Specification: 25 mg/100 mg per tablet, 30 tablets per bottle
-
Ponatinib｜Acute Lymphoblastic Leukemia
- Generic Name/Brand Name: Ponatinib/Iclusig
- Indications: Acute Lymphoblastic Leukemia
- Dosage Form: Film-coated tablets
- Specification: 15 mg and 45 mg strengths
-
Qiyoukang (Gumokimab) – Plaque
- Generic Name/Brand Name: Gumokimab/Qiyoukang
- Indications: Moderate-to-severe plaque psoriasis in adults
- Dosage Form: Injection (subcutaneous)
- Specification: 150 mg/1 prefilled pen per box
-
Yizekang (Izalontamab Brengitecan) – NPC/ESCC
- Generic Name/Brand Name: Izalontamab Brengitecan/Yizekang
- Indications: Recurrent or metastatic nasopharyngeal carcinoma (NPC); Recurrent or metastatic esophageal squamous cell carcinoma (ESCC)
- Dosage Form: Injection
- Specification: 120 mg/vial
